Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lena Machetanz has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Role of Social Determinants in Forensic Outcomes of Schizophrenia Spectrum Disorders: A Machine Learning-Supported Cohort Study

    by Everardo Neumann Guerra, Andreas B. Hofmann, Johannes Kirchebner, Marc Dörner, Lena Machetanz

    Maintaining a healthy social network is a pervasive challenge among individuals with schizophrenia spectrum disorders (SSD), profoundly influencing mental health outcomes and social functioning. While social adversities such as social isolation may not be a direct cause of criminal behavior, they may act as a significant risk factor. Previous results from offenders with SSD indicated that attention disorder, alogia, crime motivated by ego disturbances, overall symptom severity, and a history of negative symptoms were the most influential factors in predicting social isolation in this population. The present study aims to examine whether specific social determinants can distinguish between forensic and non-forensic patients with SSD, thereby addressing the research question of whether these factors are associated with an increased risk of offending in this population. The comparative pattern analysis was conducted using a variety of machine learning models. A history of social isolation, relationship status upon discharge from the institution, social marginalization during childhood, complete compulsory schooling, and contact with the mental health services through family members demonstrated the highest capacity to distinguish between these two groups. Factors related to psychopathology however were statistically outperformed in the prediction model, which yielded an AUC of 0.83. The study’s results highlight determinants of offending related to social integration/isolation as an outcome of SSD and possibly indicating potential preventative measures regarding offending SSD patients.

  • Elektrokonvulsionstherapie unter Zwang im stationären Massnahmenvollzug

    by Lena Machetanz, Michael Pommerehne, Gian Ege, Madeleine Kassar, Elmar Habermeyer, Johannes Kirchebner

    Die forensische Psychiatrie hat ein Doppelmandat: Sie zielt nicht nur darauf ab, das individuelle Leiden eines Patienten oder einer Patientin zu lindern, sondern auch das Risiko von erneuten Gewalttaten aufgrund der Erkrankung zu reduzieren. Dabei stehen Fachpersonen oft vor der Herausforderung, mit schweren psychiatrischen Erkrankungen umzugehen, die auch auf intensive therapeutische Bemühungen nicht hinreichend ansprechen. In diesem Spannungsfeld liegt die Verantwortung darin, ärztliches Handeln an medizinischen und ethischen Prinzipien auszurichten und gleichzeitig gesetzlichen Vorgaben zu folgen. Anhand eines Fallbeispiels aus der Schweiz wird deutlich gemacht, wie diese Herausforderung konkret werden kann: Die Frage, ob ein psychisch kranker Mensch mit therapierefraktärer Schizophrenie und fehlenden Rehabilitationsperspektiven auch gegen seinen Willen einer Elektrokonvulsionstherapie unterzogen werden darf, wird aus medizinischer, ethischer und juristischer Perspektive beleuchtet.

  • Open Access

    Differences between criminal offender versus non-offender female patients with schizophrenia spectrum disorder: a retrospective cohort study

    by Lynn Jacobshagen, Lena Machetanz, Johannes Kirchebner

    The purpose of this study was to investigate the difference between offender female patients (OFS) and non-offender female patients (NOFS) with schizophrenia spectrum disorder (SSD). The patients in this study were admitted to the university psychiatry in Zurich Switzerland between 1982 and 2016. Demography, psychopathology, comorbidity, and treatment differences were analyzed using binary statistics to compare 31 OFS and 29 matching NOFS with SSD. The Fisher‘s exact test was used for categorical data variables in small size samples and the Mann-Whitney-U-Test for nonparametric test variables, adjusted with the Benjamini and Hochberg method. The results indicate that the NOFS were cognitively more impaired, they were more likely to have had antipsychotic drugs prescribed (NOFS; 100%, OFS: 71%, OR 1.41, 95% CI 1.13-1.77, p=0.022) and their medication compliance was higher (NOFS: 84.6%, OFS: 4.5%, OR 0.09, 95% CI 0.00-0.08, p=0.000). In contrast, the OFS had completed compulsory school less often and the were observed to be more often homeless and socially isolated (OFS: 72.4%, NOFS: 34.6%, OR 4.96, 95% CI 1.58-15.6, p=0.026), self-disorders (OFS: 51.6%, NOFS: 11.1%, OR 8.53, 95% CI 2.12-34.32, p=0.011), delusions (OFS: 96.8%, NOFS: 63%, OR 17.65, 95% CI 2.08-149.99, p=0.014) and substance use disorder (51.6%, OR 0.27, 95% CI 0.09-0.85, p=0.039). Clinicians treating female offender patients with SSD should focus more on the treatment for substance use disorder, medication and early recognition of the illness for preventative purposes.


  • Open Access

    Offenders and non-offenders with schizophrenia spectrum disorders: the crime-preventive potential of sufficient embedment in the mental healthcare and support system

    by Lena Machetanz, Andreas B. Hofmann, Jan Möhrke, Johannes Kirchebner

    Background: Suffering from schizophrenia spectrum disorder (SSD) has been well-established as a risk factor for offending. However, the majority of patients with an SSD do not show aggressive or criminal behavior. Yet, there is little research on clinical key features distinguishing offender from non-offender patients. Previous results point to poorer impulse control, higher levels of excitement, tension, and hostility, and worse overall cognitive functioning in offender populations. This study aimed to detect the most indicative distinguishing clinical features between forensic and general psychiatric patients with SSD based on the course of illness and the referenced hospitalization in order to facilitate a better understanding of the relationship between violent and non-violent offenses and SSD.Methods: Our study population consisted of forensic psychiatric patients (FPPs) with a diagnosis of F2x (ICD-10) or 295.x (ICD-9) and a control group of general psychiatric patients (GPPs) with the same diagnosis, totaling 740 patients. Patients were evaluated regarding their medical (and, if applicable, criminal) history and the referenced psychiatric hospitalization. Supervised machine learning (ML) was used to exploratively evaluate predictor variables and their interplay and rank them in accordance with their discriminative power.Results: Out of 194 possible predictor variables, the following 6 turned out to have the highest influence on the model: olanzapine equivalent at discharge from the referenced hospitalization, a history of antipsychotic prescription, a history of antidepressant, benzodiazepine or mood stabilizer prescription, medication compliance, outpatient treatment(s) in the past, and the necessity of compulsory measures. Out of the seven algorithms applied, gradient boosting emerged as the most suitable, with an AUC of 0.86 and a balanced accuracy of 77.5%.Discussion: Our study aimed to identify the most influential illness-related predictors, distinguishing between FPP and GPP with SSD, thus shedding light on key differences between the two groups. To our knowledge, this is the first study to compare a homogenous sample of FPP and GPP with SSD regarding their symptom severity and course of illness using highly sophisticated statistical approaches with the possibility of evaluating the interplay of all factors at play.


  • Open Access

    Offenders and non-offenders with schizophrenia spectrum disorders: Do they really differ in known risk factors for aggression?

    by Johannes Kirchebner, Steffen Lau, Lena Machetanz

    Introduction: Individuals with schizophrenia spectrum disorders (SSD) have an elevated risk for aggressive behavior, and several factors contributing to this risk have been identified, e. g. comorbid substance use disorders. From this knowledge, it could be inferred that offender patients show a higher expression of said risk factors than non-offender patients. Yet, there is a lack of comparative studies between those two groups, and findings gathered from one of the two are not directly applicable to the other due to numerous structural differences. The aim of this study therefore was to identify key differences in offender patients and non-offender patients regarding aggressive behavior through application of supervised machine learning, and to quantify the performance of the model.Methods: For this purpose, we applied seven different (ML) algorithms on a dataset comprising 370 offender patients and a comparison group of 370 non-offender patients, both with a schizophrenia spectrum disorder.Results: With a balanced accuracy of 79.9%, an AUC of 0.87, a sensitivity of 77.3% and a specificity of 82.5%, gradient boosting emerged as best performing model and was able to correctly identify offender patients in over 4/5 the cases. Out of 69 possible predictor variables, the following emerged as the ones with the most indicative power in distinguishing between the two groups: olanzapine equivalent dose at the time of discharge from the referenced hospitalization, failures during temporary leave, being born outside of Switzerland, lack of compulsory school graduation, out- and inpatient treatment(s) prior to the referenced hospitalization, physical or neurological illness as well as medication compliance.Discussion: Interestingly, both factors related to psychopathology and to the frequency and expression of aggression itself did not yield a high indicative power in the interplay of variables, thus suggesting that while they individually contribute to aggression as a negative outcome, they are compensable through certain interventions. The findings contribute to our understanding of differences between offenders and non-offenders with SSD, showing that previously described risk factors of aggression may be counteracted through sufficient treatment and integration in the mental health care system.


  • Open Access

    Correlates of Social Isolation in Forensic Psychiatric Patients with Schizophrenia Spectrum Disorders: An Explorative Analysis Using Machine Learning

    by Lena Machetanz, Steffen Lau, David Huber, Johannes Kirchebner

    The detrimental effects of social isolation on physical and mental health are well known. Social isolation is also known to be associated with criminal behavior, thus burdening not only the affected individual but society in general. Forensic psychiatric patients with schizophrenia spectrum disorders (SSD) are at a particularly high risk for lacking social integration and support due to their involvement with the criminal justice system and their severe mental illness. The present study aims to exploratively evaluate factors associated with social isolation in a unique sample of forensic psychiatric patients with SSD using supervised machine learning (ML) in a sample of 370 inpatients. Out of >500 possible predictor variables, 5 emerged as most influential in the ML model: attention disorder, alogia, crime motivated by ego disturbances, total PANSS score, and a history of negative symptoms. With a balanced accuracy of 69% and an AUC of 0.74, the model showed a substantial performance in differentiating between patients with and without social isolation. The findings show that social isolation in forensic psychiatric patients with SSD is mainly influenced by factors related to illness and psychopathology instead of factors related to the committed offences, e.g., the severity of the crime.


  • Open Access

    Suicidal Offenders and Non-Offenders with Schizophrenia Spectrum Disorders: A Retrospective Evaluation of Distinguishing Factors Using Machine Learning

    by Lena Machetanz, Steffen Lau, Elmar Habermeyer, Johannes Kirchebner

    Patients with schizophrenia spectrum disorders (SSD) have an elevated risk of suicidality. The same has been found for people within the penitentiary system, suggesting a cumulative effect for offender patients suffering from SSD. While there appear to be overlapping characteristics, there is little research on factors distinguishing between offenders and non-offenders with SSD regarding suicidality. Our study therefore aimed at evaluating distinguishing such factors through the application of supervised machine learning (ML) algorithms on a dataset of 232 offenders and 167 non-offender patients with SSD and history of suicidality. With an AUC of 0.81, Naïve Bayes outperformed all other ML algorithms. The following factors emerged as most powerful in their interplay in distinguishing between offender and non-offender patients with a history of suicidality: Prior outpatient psychiatric treatment, regular intake of antipsychotic medication, global cognitive deficit, a prescription of antidepressants during the referenced hospitalisation and higher levels of anxiety and a lack of spontaneity and flow of conversation measured by an adapted positive and negative syndrome scale (PANSS). Interestingly, neither aggression nor overall psychopathology emerged as distinguishers between the two groups. The present findings contribute to a better understanding of suicidality in offender and non-offender patients with SSD and their differing characteristics.


  • Open Access

    High Risk, High Dose?—Pharmacotherapeutic Prescription Patterns of Offender and Non-Offender Patients with Schizophrenia Spectrum Disorder

    by Lena Machetanz, Moritz Philipp Günther, Steffen Lau, Johannes Kirchebner

    Compared to acute or community settings, forensic psychiatric settings, in general, have been reported to make greater use of antipsychotic polypharmacy and/or high dose pharmacotherapy, including overdosing. However, there is a scarcity of research specifically on offender patients with schizophrenia spectrum disorders (SSD), although they make up a large proportion of forensic psychiatric patients. Our study, therefore, aimed at evaluating prescription patterns in offender patients compared to non-offender patients with SSD. After initial statistical analysis with null-hypothesis significance testing, we evaluated the interplay of the significant variables and ranked them in accordance with their predictive power through application of supervised machine learning algorithms. While offender patients received higher doses of antipsychotics, non-offender patients were more likely to receive polypharmacologic treatment as well as additional antidepressants and benzodiazepines. To the authors’ knowledge, this is the first study to evaluate a homogenous group of offender patients with SSD in comparison to non-offender controls regarding patterns of antipsychotic and other psychopharmacologic prescription patterns.


  • Inpatient forensic psychiatry in the time of COVID-19: a survey study of perceived mental health implications on people with schizophrenia spectrum disorder

    by Marc Dörner, Steffen Lau, Stefanie Schreiber, Madeleine Kassar, Lena Machetanz, Johannes Kirchebner

    The aim of our study was to assess the perceived mental health impact of the COVID-19 pandemic on people with schizophrenia spectrum disorder (SSD) in an inpatient forensic psychiatric institution ...